Literature DB >> 19786993

Kidney disease: improving global outcomes.

Kai-Uwe Eckardt1, Bertram L Kasiske.   

Abstract

Kidney Disease: Improving Global Outcomes (KDIGO) is an independent organization with the mission to improve care and outcomes of patients with kidney disease worldwide through the development and coordination of clinical practice guidelines. KDIGO has established firm links with other organizations that have previously produced clinical practice guidelines in the field of kidney disease. The first three KDIGO guidelines--treatment of hepatitis C, management of bone and mineral disease, and care of kidney transplant recipients--have been finalized and the next three--acute kidney injury, management of glomerulonephritis, and management of blood pressure in chronic kidney disease--are under development. The ultimate goal is to cover most major aspects of care for patients with kidney disease. Corner stones of KDIGO's guideline development process are independent, multidisciplinary, international work groups, close collaboration with professional methodology experts who perform systematic evidence reviews, and open public review of each guideline. Grades of Recommendation Assessment, Development, and Evaluation (GRADE) methodology is applied for grading the quality of evidence and strength of recommendations. International conferences organized by KDIGO support the coordination of guideline development, assess the suitability of guideline topics and help to establish global consensus on definitions and policies.

Entities:  

Mesh:

Year:  2009        PMID: 19786993     DOI: 10.1038/nrneph.2009.153

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


  34 in total

1.  Relationships between authors of clinical practice guidelines and the pharmaceutical industry.

Authors:  Niteesh K Choudhry; Henry Thomas Stelfox; Allan S Detsky
Journal:  JAMA       Date:  2002-02-06       Impact factor: 56.272

2.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

3.  II. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults.

Authors: 
Journal:  Am J Kidney Dis       Date:  2006-05       Impact factor: 8.860

4.  A report of the Lisbon Conference on the care of the kidney transplant recipient.

Authors:  Mario Abbud-Filho; Patricia L Adams; Josefina Alberú; Carl Cardella; Jeremy Chapman; Pierre Cochat; Fernando Cosio; Gabriel Danovitch; Connie Davis; Robert S Gaston; Atul Humar; Lawrence G Hunsicker; Michelle A Josephson; Bertram Kasiske; Günter Kirste; Alan Leichtman; Stephen Munn; Gregorio T Obrador; Annika Tibell; Jonas Wadström; Martin Zeier; Francis L Delmonico
Journal:  Transplantation       Date:  2007-04-27       Impact factor: 4.939

5.  Reassessment of clinical practice guidelines: go gently into that good night.

Authors:  Terrence M Shaneyfelt; Robert M Centor
Journal:  JAMA       Date:  2009-02-25       Impact factor: 56.272

6.  Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

Authors:  Francesco Locatelli; Allen R Nissenson; Brendan J Barrett; Rowan G Walker; David C Wheeler; Kai U Eckardt; Norbert H Lameire; Garabed Eknoyan
Journal:  Kidney Int       Date:  2008-07-02       Impact factor: 10.612

7.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

8.  KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease.

Authors: 
Journal:  Kidney Int Suppl       Date:  2008-04       Impact factor: 10.545

9.  NKF-DOQI clinical practice guidelines for vascular access. National Kidney Foundation-Dialysis Outcomes Quality Initiative.

Authors: 
Journal:  Am J Kidney Dis       Date:  1997-10       Impact factor: 8.860

10.  Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes.

Authors:  A S Levey; R Atkins; J Coresh; E P Cohen; A J Collins; K-U Eckardt; M E Nahas; B L Jaber; M Jadoul; A Levin; N R Powe; J Rossert; D C Wheeler; N Lameire; G Eknoyan
Journal:  Kidney Int       Date:  2007-06-13       Impact factor: 10.612

View more
  25 in total

1.  Albumin testing in urine using a smart-phone.

Authors:  Ahmet F Coskun; Richie Nagi; Kayvon Sadeghi; Stephen Phillips; Aydogan Ozcan
Journal:  Lab Chip       Date:  2013-11-07       Impact factor: 6.799

2.  Serum Iron Protects from Renal Postischemic Injury.

Authors:  Céline Vaugier; Mariane T Amano; Jonathan M Chemouny; Michael Dussiot; Claire Berrou; Marie Matignon; Sanae Ben Mkaddem; Pamella H M Wang; Aurélie Fricot; Thiago T Maciel; Damien Grapton; Jacques R R Mathieu; Carole Beaumont; Marie-Noëlle Peraldi; Carole Peyssonnaux; Laurent Mesnard; Eric Daugas; François Vrtovsnik; Renato C Monteiro; Olivier Hermine; Yelena Z Ginzburg; Marc Benhamou; Niels O S Camara; Martin Flamant; Ivan C Moura
Journal:  J Am Soc Nephrol       Date:  2017-08-07       Impact factor: 10.121

3.  Comparison of concurrent complications of CKD by 2 risk categorization systems.

Authors:  Lesley A Inker; Marcello Tonelli; Brenda R Hemmelgarn; Emily B Levitan; Paul Muntner
Journal:  Am J Kidney Dis       Date:  2011-11-23       Impact factor: 8.860

4.  Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in mice.

Authors:  Satoko Arai; Kento Kitada; Tomoko Yamazaki; Ryosuke Takai; Xizhong Zhang; Yoji Tsugawa; Ryoichi Sugisawa; Ayaka Matsumoto; Mayumi Mori; Yasunori Yoshihara; Kent Doi; Natsumi Maehara; Shunsuke Kusunoki; Akiko Takahata; Eisei Noiri; Yusuke Suzuki; Naoki Yahagi; Akira Nishiyama; Lakshman Gunaratnam; Tomoko Takano; Toru Miyazaki
Journal:  Nat Med       Date:  2016-01-04       Impact factor: 53.440

5.  Fibrinogen β-derived Bβ(15-42) peptide protects against kidney ischemia/reperfusion injury.

Authors:  Aparna Krishnamoorthy; Amrendra Kumar Ajay; Dana Hoffmann; Tae-Min Kim; Victoria Ramirez; Gabriela Campanholle; Norma A Bobadilla; Sushrut S Waikar; Vishal S Vaidya
Journal:  Blood       Date:  2011-06-17       Impact factor: 22.113

6.  Putative episodes of T-cell-mediated rejection in patients with sustained BK viruria but no viremia.

Authors:  Kosuke Masutani; Ron Shapiro; Amit Basu; Henkie Tan; Toshiharu Ninomiya; Parmjeet Randhawa
Journal:  Transplantation       Date:  2012-07-15       Impact factor: 4.939

Review 7.  Acute Kidney Injury Induced by Immune Checkpoint Inhibitors.

Authors:  Ruixue Tian; Jin Liang; Rongshan Li; Xiaoshuang Zhou
Journal:  Kidney Dis (Basel)       Date:  2022-04-04

Review 8.  Dental implant treatment for renal failure patients on dialysis: a clinical guideline.

Authors:  Quan Yuan; Qiu-Chan Xiong; Megha Gupta; Rosa María López-Pintor; Xiao-Lei Chen; Dutmanee Seriwatanachai; Michael Densmore; Yi Man; Ping Gong
Journal:  Int J Oral Sci       Date:  2017-06-23       Impact factor: 6.344

Review 9.  Polyoma virus nephropathy in kidney transplantation.

Authors:  Jacob Rw Scadden; Adnan Sharif; Kassi Skordilis; Richard Borrows
Journal:  World J Transplant       Date:  2017-12-24

10.  The addition of sodium thiosulphate to hyperthermic intraperitoneal chemotherapy with cisplatin in ovarian cancer.

Authors:  Kate Glennon; Karen Mulligan; Kirsten Carpenter; Ruth Mooney; Jurgen Mulsow; Orla McCormack; William Boyd; Tom Walsh; Ruaidhri McVey; Claire Thompson; Brid Ryan; Katie Padfield; Patrick Murray; Donal J Brennan
Journal:  Gynecol Oncol Rep       Date:  2021-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.